CA
TYRA icon

Clearstead Advisors’s Tyra Biosciences TYRA Stock Holding History

Clearstead Advisors’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.1K Hold
29
– – ﹤0.01% 2026
2025
Q4 		$759 Sell
29
-96
-77% -$1.76K ﹤0.01% 2260
2025
Q3 		$1.75K Hold
125
– – ﹤0.01% 2484
2025
Q2 		$1.2K Buy
+125
New +$1.19K ﹤0.01% 2411

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Clearstead Advisors's TYRA Position: Q1 2026 in Review

Clearstead Advisors held its Tyra Biosciences (TYRA) position steady in Q1 2026 at 29 shares worth $1.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2026.

Clearstead Advisors first reported a position in TYRA in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.75K in Q3 2025. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Clearstead Advisors held 29 shares of Tyra Biosciences worth $1.1K as of Q1 2026.
  • Clearstead Advisors left its Tyra Biosciences share count unchanged in Q1 2026.
  • Tyra Biosciences made up ﹤0.01% of Clearstead Advisors's portfolio in Q1 2026, its #2026 holding.
  • Clearstead Advisors first reported a position in Tyra Biosciences in Q2 2025 and has held it in 4 quarters since.
  • Clearstead Advisors's Tyra Biosciences position peaked at $1.75K in Q3 2025.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Clearstead Advisors's 13F filing for Q1 2026, filed 6 May 2026.